{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:02:26Z","timestamp":1787731346359,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA047142"],"award-info":[{"award-number":["K01DA047142"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Medications for opioid use disorder (MOUD) are associated with positive health outcomes. People remaining on MOUD have a reduced likelihood of drug overdose and mortality. Tanzania supports a national opioid treatment program (OTP) offering MOUD, but retention is a continual challenge. To date, most research on MOUD retention in Tanzania and other Sub-Saharan Africa settings has been focused on the individual-level, with little attention to economic, social, and clinic-level factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We qualitatively examined economic, social, and clinic factors that affect retention on MOUD, specifically methadone maintenance therapy, among former and current clients attending an OTP clinic Dar es Salaam, Tanzania. We conducted in-depth interviews with a total of 40 current and former clients receiving MOUD and four focus groups with an additional 35 current clients on MOUD between January and April 2020. We utilized a thematic analysis approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Daily OTP clinic attendance posed a financial burden to current and former clients and was a barrier to remaining on MOUD. Though treatment is free, clients described struggles to attend clinic, including being able to afford transportation. Female clients were differentially impacted, as sex work was the most common income-generating activity that they participated in, which presented its own set of unique challenges, including barriers to attending during set clinic hours. Drug use stigma acted as a barrier to MOUD and prevented clients from securing a job, rebuilding trust within the community, and accessing transportation to attend the clinic. Being able to rebuild trust with family facilitated remaining on MOUD, as family provided social and financial support. Caretaking responsibilities and familial expectations among female clients conflicted with MOUD adherence. Finally, clinic level factors, such as clinic dispensing hours and punitive consequences for breaking rules, posed barriers to clients on MOUD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Social and structural factors, both within (e.g., clinic policies) and outside of (e.g., transportation) the clinic impact MOUD retention. Our findings can inform interventions and policies to address economic and social barriers to MOUD, that can\u00a0contribute to sustained recovery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-023-00374-1","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T15:03:56Z","timestamp":1679929436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study"],"prefix":"10.1186","volume":"18","author":[{"given":"Deja","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iddi Haruna","family":"Nkya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Solon","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kidorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Latkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-0635","authenticated-orcid":false,"given":"Haneefa T.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"374_CR1","doi-asserted-by":"crossref","unstructured":"Ball JC, Ross A. The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcome. 1991.","DOI":"10.1007\/978-1-4613-9089-3"},{"key":"374_CR2","first-page":"1049","volume":"6","author":"DS Metzger","year":"1993","unstructured":"Metzger DS, Woody GE, McLellan AT, O\u2019Brien CP, Druley P, Navaline H, et al. Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6:1049.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"374_CR3","first-page":"8","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:8.","journal-title":"BMJ"},{"issue":"2","key":"374_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2105\/AJPH.84.2.207","volume":"84","author":"A Umbricht-Schneiter","year":"1994","unstructured":"Umbricht-Schneiter A, Ginn DH, Pabst KM, Bigelow GE. Providing medical care to methadone clinic patients: referral vs on-site care. Am J Public Health. 1994;84(2):207\u201310.","journal-title":"Am J Public Health"},{"issue":"2","key":"374_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1176\/appi.ps.201300235","volume":"65","author":"CA Fullerton","year":"2014","unstructured":"Fullerton CA, Kim M, Thomas CP, Lyman DR, Montejano LB, Dougherty RH, et al. Medication-assisted treatment with methadone: assessing the evidence. Psychiatr Serv. 2014;65(2):146\u201357.","journal-title":"Psychiatr Serv"},{"issue":"9","key":"374_CR6","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1086\/630209","volume":"49","author":"P Roux","year":"2009","unstructured":"Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, et al. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clin Infect Dis. 2009;49(9):1433\u201340.","journal-title":"Clin Infect Dis"},{"key":"374_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.drugpo.2016.03.005","volume":"30","author":"O Ubuguyu","year":"2016","unstructured":"Ubuguyu O, Tran OC, Bruce RD, Masao F, Nyandindi C, Sabuni N, et al. Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam. Tanzania Int J Drug Policy. 2016;30:74\u201381.","journal-title":"Tanzania Int J Drug Policy"},{"issue":"4","key":"374_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10461-008-9489-7","volume":"14","author":"M Malta","year":"2010","unstructured":"Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14(4):731\u201347.","journal-title":"AIDS Behav"},{"issue":"5","key":"374_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/cid\/ciu382","volume":"59","author":"BH Lambdin","year":"2014","unstructured":"Lambdin BH, Masao F, Chang O, Kaduri P, Mbwambo J, Magimba A, et al. Methadone treatment for HIV prevention\u2014feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. Clin Infect Dis. 2014;59(5):735\u201342.","journal-title":"Clin Infect Dis"},{"key":"374_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/ADM.0000000000000995","volume":"16","author":"DA Mlaki","year":"2022","unstructured":"Mlaki DA, Mbwambo JK, McCurdy S, Masao FA, Kaduri PA. Twelve-month treatment retention and associated factors: a comparison of 2 medically assisted therapy clinics in Dar es Salaam. Tanzania J Addict Med. 2022;16:382.","journal-title":"Tanzania. J Addict Med."},{"key":"374_CR11","first-page":"6","volume":"9","author":"M Karekla","year":"2019","unstructured":"Karekla M, Kasinopoulos O, Neto DD, Ebert DD, Van Daele T, Nordgreen T, et al. Best practices and recommendations for digital interventions to improve engagement and adherence in chronic illness sufferers. Eur Psychologist. 2019;9:6.","journal-title":"Eur Psychologist."},{"issue":"1","key":"374_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-018-0787-z","volume":"17","author":"M Khazaee-Pool","year":"2018","unstructured":"Khazaee-Pool M, Moeeni M, Ponnet K, Fallahi A, Jahangiri L, Pashaei T. Perceived barriers to methadone maintenance treatment among Iranian opioid users. Int J Equity Health. 2018;17(1):1\u201310.","journal-title":"Int J Equity Health"},{"issue":"1","key":"374_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0272-7358(92)90092-M","volume":"12","author":"MJ Stark","year":"1992","unstructured":"Stark MJ. Dropping out of substance abuse treatment: A clinically oriented review. Clin Psychol Rev. 1992;12(1):93\u2013116.","journal-title":"Clin Psychol Rev"},{"issue":"12\u201314","key":"374_CR14","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3109\/10826080009148253","volume":"35","author":"LM Najavits","year":"2000","unstructured":"Najavits LM, Crits-Christoph P, Dierberger A. Clinicians\u2019 impact on the quality of substance use disorder treatment. Subst Use Misuse. 2000;35(12\u201314):2161\u201390.","journal-title":"Subst Use Misuse"},{"key":"374_CR15","first-page":"1","volume":"56","author":"HT Saleem","year":"2022","unstructured":"Saleem HT, Knight D, Yang C, Kidorf M, Latkin C, Nkya IH. HIV Stigma, HIV status disclosure, and ART adherence in the context of an integrated opioid use disorder and HIV treatment setting in Dar es Salaam. Tanzania AIDS Care. 2022;56:1\u20134.","journal-title":"Tanzania. AIDS Care."},{"key":"374_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugpo.2015.12.009","volume":"30","author":"HT Saleem","year":"2016","unstructured":"Saleem HT, Mushi D, Hassan S, Bruce RD, Cooke A, Mbwambo J, et al. \u201cCan\u2019t you initiate me here?\u201d: Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam. Tanzania Int J Drug Policy. 2016;30:59\u201365.","journal-title":"Tanzania Int J Drug Policy"},{"issue":"6","key":"374_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0277-9536(00)00065-4","volume":"51","author":"LF Berkman","year":"2000","unstructured":"Berkman LF, Glass T, Brissette I, Seeman TE. From social integration to health: Durkheim in the new millennium. Soc Sci Med. 2000;51(6):843\u201357.","journal-title":"Soc Sci Med"},{"key":"374_CR18","volume-title":"Constructing grounded theory: A practical guide through qualitative analysis","author":"K Charmaz","year":"2006","unstructured":"Charmaz K. Constructing grounded theory: A practical guide through qualitative analysis. New York: Sage; 2006."},{"issue":"4","key":"374_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0740-5472(98)00037-3","volume":"16","author":"Y-I Hser","year":"1999","unstructured":"Hser Y-I, Polinsky ML, Maglione M, Anglin MD. Matching clients\u2019 needs with drug treatment services. J Subst Abuse Treat. 1999;16(4):299\u2013305.","journal-title":"J Subst Abuse Treat"},{"issue":"13","key":"374_CR20","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1080\/10826084.2020.1797810","volume":"55","author":"S Magura","year":"2020","unstructured":"Magura S, Marshall T. The effectiveness of interventions intended to improve employment outcomes for persons with substance use disorder: an updated systematic review. Subst Use Misuse. 2020;55(13):2230\u20136.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"374_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1037\/0033-2909.117.3.416","volume":"117","author":"JJ Platt","year":"1995","unstructured":"Platt JJ. Vocational rehabilitation of drug abusers. Psychol Bull. 1995;117(3):416.","journal-title":"Psychol Bull"},{"issue":"4","key":"374_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1080\/10826084.2019.1692035","volume":"55","author":"J Harrison","year":"2020","unstructured":"Harrison J, Krieger MJ, Johnson HA. Review of individual placement and support employment intervention for persons with substance use disorder. Subst Use Misuse. 2020;55(4):636\u201343.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"374_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0376-8716(98)00005-2","volume":"50","author":"M Kidorf","year":"1998","unstructured":"Kidorf M, Hollander JR, King VL, Brooner RK. Increasing employment of opioid dependent outpatients: an intensive behavioral intervention. Drug Alcohol Depend. 1998;50(1):73\u201380.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"374_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/09595230500102434","volume":"24","author":"R Room","year":"2005","unstructured":"Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143\u201355.","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"374_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/10550490591006924","volume":"14","author":"SJ Semple","year":"2005","unstructured":"Semple SJ, Grant I, Patterson TL. Utilization of drug treatment programs by methamphetamine users: The role of social stigma. American Journal on Addictions. 2005;14(4):367\u201380.","journal-title":"American Journal on Addictions"},{"issue":"2\u20133","key":"374_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.10.014","volume":"88","author":"J Ahern","year":"2007","unstructured":"Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2\u20133):188\u201396.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"374_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","volume":"107","author":"JD Livingston","year":"2012","unstructured":"Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39\u201350.","journal-title":"Addiction"},{"issue":"9","key":"374_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1192\/pb.bp.107.018457","volume":"32","author":"J Luty","year":"2008","unstructured":"Luty J, Rao H, Arokiadass SMR, Easow JM, Sarkhel A. The repentant sinner: methods to reduce stigmatised attitudes towards mental illness. Psychiatr Bull. 2008;32(9):327\u201332.","journal-title":"Psychiatr Bull"},{"issue":"6","key":"374_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1192\/pb.bp.108.020925","volume":"33","author":"J Luty","year":"2009","unstructured":"Luty J, Umoh O, Nuamah F. Effect of brief motivational interviewing on stigmatised attitudes towards mental illness. Psychiatr Bull. 2009;33(6):212\u20134.","journal-title":"Psychiatr Bull"},{"issue":"3","key":"374_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/apc.2014.0207","volume":"29","author":"JC Kerr","year":"2015","unstructured":"Kerr JC, Valois RF, DiClemente RJ, Carey MP, Stanton B, Romer D, et al. The effects of a mass media HIV-risk reduction strategy on HIV-related stigma and knowledge among African American adolescents. AIDS Patient Care STDS. 2015;29(3):150\u20136.","journal-title":"AIDS Patient Care STDS"},{"issue":"10","key":"374_CR31","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s10461-018-2174-6","volume":"22","author":"TE Flickinger","year":"2018","unstructured":"Flickinger TE, DeBolt C, Xie A, Kosmacki A, Grabowski M, Waldman AL, et al. Addressing stigma through a virtual community for people living with HIV: a mixed methods study of the positivelinks mobile health intervention. AIDS Behav. 2018;22(10):3395\u2013406.","journal-title":"AIDS Behav"},{"issue":"1","key":"374_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-019-0355-x","volume":"17","author":"M Kermode","year":"2020","unstructured":"Kermode M, Choudhurimayum RS, Rajkumar LS, Haregu T, Armstrong G. Retention and outcomes for clients attending a methadone clinic in a resource-constrained setting: a mixed methods prospective cohort study in Imphal. Northeast India Harm Reduction J. 2020;17(1):1\u201317.","journal-title":"Northeast India Harm Reduction J"},{"issue":"1","key":"374_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-021-00378-7","volume":"16","author":"TC Silva","year":"2021","unstructured":"Silva TC, Andersson FB. The \u201cblack box\u201d of treatment: Patients\u2019 perspective on what works in opioid maintenance treatment for opioid dependence. Substance Abuse Treatment Prev Policy. 2021;16(1):1\u201315.","journal-title":"Substance Abuse Treatment Prev Policy"},{"key":"374_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108347","volume":"127","author":"R Abadie","year":"2021","unstructured":"Abadie R, McLean K, Habecker P, Dombrowski K. Treatment trajectories and barriers in opioid agonist therapy for people who inject drugs in rural Puerto Rico. J Subst Abuse Treat. 2021;127: 108347.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"374_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0189-3","volume":"14","author":"K Hayashi","year":"2017","unstructured":"Hayashi K, Ti L, Ayutthaya PPN, Suwannawong P, Kaplan K, Small W, et al. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study. Harm Reduct J. 2017;14(1):1\u20138.","journal-title":"Harm Reduct J"},{"issue":"3","key":"374_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/dar.12442","volume":"36","author":"S Larney","year":"2017","unstructured":"Larney S, Zador D, Sindicich N, Dolan K. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales. Australia Drug Alcohol Rev. 2017;36(3):305\u201310.","journal-title":"Australia Drug Alcohol Rev"},{"key":"374_CR37","first-page":"117822181668508","volume":"11","author":"J Woo","year":"2017","unstructured":"Woo J, Bhalerao A, Bawor M, Bhatt M, Dennis B, Mouravska N, et al. \u201cDon\u2019t judge a book by its cover\u201d: A qualitative study of methadone patients\u2019 experiences of stigma. Subst Abuse. 2017;11:1178221816685087.","journal-title":"Subst Abuse"},{"issue":"10","key":"374_CR38","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1080\/10826084.2018.1424913","volume":"53","author":"N Feng","year":"2018","unstructured":"Feng N, Lin C, Hsieh J, Rou K, Li L. Family related factors and concurrent heroin use in methadone maintenance treatment in China. Subst Use Misuse. 2018;53(10):1674\u201380.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"374_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/10826084.2017.1342662","volume":"53","author":"K McElrath","year":"2018","unstructured":"McElrath K. Medication-assisted treatment for opioid addiction in the United States: Critique and commentary. Subst Use Misuse. 2018;53(2):334\u201343.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"374_CR40","doi-asserted-by":"publisher","first-page":"215824401452263","DOI":"10.1177\/2158244014522633","volume":"4","author":"S Elo","year":"2014","unstructured":"Elo S, K\u00e4\u00e4ri\u00e4inen M, Kanste O, P\u00f6lkki T, Utriainen K, Kyng\u00e4s H. Qualitative content analysis: a focus on trustworthiness. SAGE Open. 2014;4(1):2158244014522633.","journal-title":"SAGE Open"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-023-00374-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T15:04:06Z","timestamp":1679929446000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-023-00374-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1186\/s13722-023-00374-1","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by ethical review committees at the Muhimbili University of Health and Allied Sciences, the National Institute for Medical Research in Tanzania, and the Johns Hopkins University Bloomberg School of Public Health. We obtained permission to conduct the study from the Muhimbili National Hospital. All study participants provided informed consent prior to participation. To maintain confidentiality names and other identifying information have been omitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}